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ABSTRACT:  In the U.S. health care system, and in those of many other countries, the care of 
dying patients is generally not performed well, with pain and other distress frequently under-
treated and patients’ preferences not respected. England’s evidence-based End of Life Care 
Strategy could prove instructive. This issue brief discusses the origins, content, and imple-
mentation of the Strategy, as well as its potential impact. Both England and the United States 
struggle with similar challenges, including looking beyond the province of hospice and palli-
ative-care specialists and initiating palliative services before the patient’s final days. Aspects of 
the English approach that may be useful in the United States include strategies to help physi-
cians recognize when patients are entering a trajectory that may end in death, the use of “death 
at home” as a metric for measuring progress, improving the skills of clinical and caregiving 
personnel through Web-based training, and developing a national improvement pathway.
                    
OVERVIEW
Ideally, the care of patients at the end of life would be humane, respectful of their 
dignity and wishes, and helpful in coping with the accompanying physical and psy-
chological insults. But the reality is too often quite different. What happens to us at 
the end of life depends very much on the health care system of a country. And in the 
American system,1 and those of many other nations, the care of dying patients is gen-
erally not performed well.
In the only available international comparison of care at the end of life, the 
Economist magazine’s Economist Intelligence Unit (EIU) developed and applied a 
“quality of death” index made up of some 24 indicators pertaining to the basic end-
of-life care environment as well as to the availability, cost, and quality of end-of-life 
care. In the 2010 report, The Quality of Death: Ranking End-of-Life Care Across the 
World, the EIU made comparisons among 40 countries. The United Kingdom and 
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Australia were ranked as having the best quality of death. 
The United States tied with Canada for 9th place.2 
This does not necessarily mean that end-of-life 
care in any country approaches the ideal. In fact, the 
United States is ahead of the U.K. in some respects—for 
example, a higher percentage of patients receive hos-
pice and palliative care in the U.S. at the end of life. An 
important difference between the two countries, however, 
is that the U.K. made a governmental decision in 2008 to 
adopt a systematic strategy to improve end-of-life care. 
This issue brief addresses England’s End of Life 
Care Strategy—a 10-year plan that was adopted in 2008 
by the country’s Department of Health and National 
Health Service.3,4 England’s adoption of the Strategy 
provides an opportunity to see how improvements in 
end-of-life care are being pursued in a health system that 
was already, in international terms, doing relatively well. 
The author discusses why the strategy came about, what 
it consists of, how it is being implemented, and what is 
known about its impact.5 This account is based both on 
published sources and on some 15 interviews in London 
in early 2010 with individuals who have been deeply 
involved either with the Strategy and its implementation 
or with end-of-life and palliative care.6 
A CHALLENGE FOR THE UNITED STATES
Though most Americans (71 percent in a recent survey7) 
say that their home is their preferred place of death, only 
25 percent of U.S. deaths occur at home.8 Most of the 
2.5 million deaths each year in the United States occur in 
institutional settings (45 percent in hospitals and 22 per-
cent in nursing homes)9 and over 25 percent of Medicare 
expenditures go to beneficiaries’ final year of life.10 
Moreover, researchers have found that the pain 
and other kinds of distress that commonly occur among 
dying patients are frequently undertreated in the U.S.11 
Medicare’s hospice benefit, though intended to facilitate 
palliative care (relief or prevention of pain and suffering) 
at the end of life, is limited to patients who forgo other 
treatment for their terminal illness; the benefit is used 
by fewer than 40 percent of dying patients, often only in 
the last few days of life.12 (The median length of stay in a 
hospice is about 20 days, and about one-third of patients 
live less than a week after admission.) In general, com-
munication about end-of-life care between patients (or 
their families) and the patient-care team is inadequate, 
sometimes resulting in unwanted interventions that only 
prolong the dying process.13 Clearly there are discrepan-
cies between the care that people envision for themselves 
and the care they typically receive. 
The challenge of improving end-of-life care in 
the United States was tackled in 1997 in the Institute 
of Medicine report Approaching Death.14 Although its 
authors recognized positive developments in hospice care, 
palliative care, and patient autonomy, they found major 
problems in the quality of end-of-life care and recom-
mended many ways to make improvements. However, 
none of these recommendations was directed at any spe-
cific entities—governmental or nongovernmental—that 
could be held accountable for implementing them. 
How might the challenge be handled in a differ-
ent health care system?
WHY AN END-OF-LIFE CARE STRATEGY  
IN THE U.K.? 
As defined by British policymakers, “end-of-life care” 
should help people with advanced, progressive, and 
incurable illnesses to live as well as possible until they 
die.15 But there was considerable evidence in the mid-
2000s that end-of-life care was inadequate in England, 
despite the excellent models that existed there—particu-
larly in the hospices that had been introduced as chari-
table organizations several decades earlier. The majority 
of deaths in England occurred in hospitals, even though 
surveys indicated that few people stated a preference 
for hospitals as the places where they would wish to die 
(50%–70% said they would prefer to die at home).16 
About half of the 16,000 complaints within the National 
Health Service (NHS) from July 2004 to July 2006 per-
tained to care given in acute hospitals, and within that 
fraction 54 percent related to end-of-life care.17 The pri-
mary criticisms involved communication problems, lack 
of basic comfort, inadequate symptom control, unmet 
psychological needs, and late referral to specialist pallia-
tive care. Care within hospitals thus came to be flagged 
by the NHS as a critical problem. 
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Demographic trends lent urgency to the need for 
improvement. The number of deaths, particularly among 
the very old, was certain to increase substantially over 
the next decade. This added an important, if implicit, 
economic dimension to the issue. Although the Strategy 
was not proposed as a way to save money, there was hope 
that such care could be improved without adding to the 
overall cost of health care. This objective seemed feasible, 
given that a review of the evidence by the U.K. National 
Audit Office suggested that many hospital admissions for 
patients at the end of life were avoidable, resulting from 
problems such as lack of access to timely advice and med-
ications for people living at home and in nursing homes, 
as well as coordination problems among the different 
organizations that provided care near the end of life (e.g., 
ambulance services and out-of-hours general practitioners 
being unaware of patients’ “do not resuscitate” orders).18 
Professor Sir Mike Richards, the London oncolo-
gist and palliative-care specialist who led both in the 
development and implementation of the Strategy, identi-
fied two additional matters that it needed to address.19 
First, a general societal reluctance to talk openly about 
death and dying meant that few people were discussing 
their care preferences with relatives or friends and that 
professionals were reluctant to initiate conversations with 
patients about these matters. Second, end-of-life care 
had a low profile within the National Health Service and 
social-service organizations. Having not been identified 
as a priority, the quality of end-of-life care was variable 
and often low.
Shortcomings in end-of-life care in Britain may 
seem surprising because it was the place of origin for the 
modern hospice concept—to provide a more humane 
alternative to the ways in which people near the end 
of life were treated in hospitals. Beginning with Dame 
Cicely Saunders’ St. Christopher’s Hospice in 1967, 
hospices became widespread in Britain, and the idea of 
palliative care that was associated with hospices gained 
widespread acceptance in many countries. However, this 
does not mean that the hospice itself was integrated into 
the health care system. In Britain, hospices developed 
as charitable organizations that were external to the 
National Health Service and its hospitals and health pro-
fessionals, though today some 40 hospices and a growing 
number of palliative-care consultant physicians are part 
of the NHS.
About the NHS
Health care in England, including hospital and physician services and prescription drugs, is provided to 
all residents through the National Health Service (NHS). The NHS is financed primarily through general 
taxation and requires very little patient cost-sharing (mainly for outpatient prescription drugs, dental 
care, and optometry care). About one of 10 residents has supplementary private insurance that covers 
the individual’s choice of specialist and faster access to elective surgery. 
Eighty percent of the NHS budget is controlled by 152 primary care trusts (PCTs), which con-
tract with physicians and hospitals to provide care to a geographically defined population. Hospitals 
are organized as trusts (responsible to England’s secretary of state for health), with varying degrees of 
autonomy. Specialists are mainly salaried hospital employees, although many supplement their income 
treating private patients. 
Since 2003, the NHS has purchased a small but increasing share of routine elective surgery 
and diagnostics from private providers. Primary care providers are mainly private, operate under an 
annual national contract, and are paid directly by PCTs through a combination of salary, capitation, and 
fee for service. The 2004 general-practitioner contract introduced a comprehensive pay-for-performance 
initiative that provides substantial financial incentives tied to achievement of clinical and other perfor-
mance targets. Since 2003, a new payment framework has been gradually introduced, basing contracts 
with acute, mental health, ambulance, and community service providers on activity. Since 2009, a pro-
portion of these providers’ incomes are conditional on quality and innovation.
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The success of hospices had a paradoxical effect. 
They came to be seen as providing Britain’s standard of 
excellence for care of the dying, but this led to feelings of 
inadequacy in the hospital settings where most patients 
die. As Professor John Ellershaw, director of the Marie 
Curie Palliative Care Institute in Liverpool, has put it, 
the “hospice model of excellence can lead to the general-
ist feeling that the only place patients can die well is in 
a hospice, resulting in de-skilling and a sense of failure 
within the health care staff who are not based within the 
hospice sector.”20 
In the mid-2000s only 16 percent of cancer 
deaths and only about 5 percent of all deaths occurred 
in hospices.21 (Hospices were also involved in the care 
related to another 5 percent of deaths that occurred else-
where.) If dying patients were to benefit from the end-
of-life care expertise associated with hospices, such care 
needed to be transferred beyond these facilities them-
selves. That was the idea behind the development of the 
approaches on which the end-of-life care strategy built.  
THE END OF LIFE CARE STRATEGY
The End of Life Care Strategy laid out 10 objectives, 
including the need to enhance public awareness, improve 
end-of-life care, and increase relevant knowledge and 
skills among health professionals (Exhibit 1). 
Several aspects of the Strategy are particularly 
notable. First, it emphasized the need for understand-
ing and respecting the wishes of patients in how they are 
cared for at the end of life, as well as for offering people 
more choice about the care they receive, particularly 
with regard to location of care (e.g., home or hospi-
tal). Professor Richards emphasized that the Strategy’s 
approach existed within the “current legal framework” 
and thus did not involve euthanasia or assisted dying.
Second, the Strategy enunciated a vision of qual-
ity of care based on what is involved in a “good death” 
for patients, including being treated as an individual and 
with dignity and respect, being without pain and other 
symptoms, and being in familiar surroundings in the 
company of close family or friends. There was an explicit 
recognition that there is no single end-of-life trajectory 
and that the process by which patients approach death 
is in part a function of the disease involved. Because the 
downward courses are typically quite different for cancer, 
organ-system failure, and frailty/dementia, for example, 
these variations need to be recognized in providing end-
of-life care.22
Third, the Strategy was evidence-based in sev-
eral respects. Research had documented the shortcom-
ings in existing end-of-life care that the Strategy sought 
to address. Also, as is discussed later in this brief, the 
Exhibit 1. Objectives of England’s End of Life Care Strategy
•	 Increasing	public	awareness	of	death	and	dying	to	facilitate	people’s	discussion	of	their	own	preferences	and	
help	drive	improvements	in	service	quality.
•	 Ensuring	that	people	are	treated	with	dignity	and	respect	at	the	end	of	their	lives.
•	 Ensuring	that	pain	and	suffering	are	kept	to	an	absolute	minimum	by	providing	access	to	skillful	symptom	
management.
•	 Ensuring	access	to	physical,	psychological,	social,	and	spiritual	care.
•	 Ensuring	that	people’s	individual	needs,	priorities,	and	preferences	for	end	of	life	care	are	identified,	
documented,	reviewed,	respected,	and	acted	upon.
•	 Ensuring	coordination	of	services	so	that	patients	receive	seamless	care.
•	 Ensuring	that	high-quality	care	is	provided	in	the	last	days	of	life	and	after	death	in	all	care	settings.
•	 Ensuring	that	caregivers	are	appropriately	supported.
•	 Ensuring	that	health	and	social	care	professionals	receive	the	education	and	training	necessary	for	providing	
high-quality	care.
•	 Ensuring	that	services	provide	good	value	for	the	money	to	the	taxpayer.
Source: Department of Health, End of Life Care Strategy: Promoting High Quality Care for All Adults at the End of Life (London: Department of Health, 2008).
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Strategy’s ideas for improving end-of-life care came from 
pertinent models and research already in existence. And 
it was recommended that a strong research component be 
built into implementation, both for monitoring progress 
and assessing outcomes. 
Fourth, a recurrent theme in the Strategy 
involved crossing boundaries that had previously limited 
the application of the best ideas and service models for 
end-of-life care. The Strategy was explicit about going 
beyond cancer care to meet the needs of all patients 
with advanced, progressive, and incurable illnesses. The 
Strategy recognized that good end-of-life care should 
be the province not only of hospices and palliative-care 
specialists and should not be limited to certain settings, 
whether hospice or hospital. (A complication for end-of-
life care in Britain is that the general practitioners with 
whom patients have ongoing relationships provide care 
exclusively outside of the hospital, as do the providers of 
social care, while disease-specific specialists are usually 
hospital employees.) The fact that some necessary services 
are provided in the voluntary and private sectors as well 
as in the National Health Service provides additional 
boundary-crossing challenges, and so does the fact that 
the care homes where many frail elderly reside lie outside 
the NHS and beyond its care and quality-control capaci-
ties. An additional boundary involved timing. Under the 
Strategy, services oriented toward the end of life could 
begin a year or more before the patient’s final days. 
These and other central ideas for improving 
patient care were built into a “care pathway” that would 
be followed by professional and organizational providers 
of care and supported by the NHS’s processes of plan-
ning, budgeting, and contracting for services. The steps 
of the care pathway were: 
•	 The physician identifies patients who are within a 
year or two of the end of life and initiates discussions 
of their care preferences.
•	 Care plans are developed for patients based on their 
needs and wishes, and these plans are regularly 
reviewed and modified as needed.
•	 A doctor or nurse coordinates a patient’s care among 
the multiple organizations with which the patient 
might deal—hospitals (and their specialists), primary 
care doctors (GPs), care (i.e., nursing) homes, out-of-
hours medical services,23 district nurses who provide 
home care, social care providers, ambulance services, 
and hospices and specialist palliative care services.
•	 These and other pertinent organizations deliver high-
quality services.
•	 Care—particularly “comfort care”—is provided to the 
patient in his or her last days of life.
•	 Care is provided after death (for the patient’s body) 
and for the needs of families and caregivers. 
Notable among these steps were the focus on 
early identification of patients who are approaching the 
end of life, the emphasis on coordination, and the rec-
ognition that death does not end the need for services 
related to end of life. And crosscutting the six steps in 
the pathway were strands reflecting the need to provide 
spiritual care, to support families and caregivers, and to 
supply high-quality information.
The elements of the Strategy’s care pathway 
were based on existing models and tools that had been 
developed in hospices and by the NHS but that were still 
only in limited use. The Strategy sought to transform 
end-of-life care by promoting the wider use of these 
models—namely, the Preferred Priorities for Care, Gold 
Standards Framework, Delivering Choice Programme, 
and Liverpool Care Pathway for the Dying Patient—each 
of which had emerged in an ad hoc way in a particular 
location or sector of the health care system in response 
to the needs of patients at the end of life. Although they 
have separate origins and different emphases, they have 
much in common. Each of these models merits brief 
description (Exhibit 2). 
Preferred priorities for care.24 Not an actual model of 
care, preferred priorities for care (PPC) is similar to the 
“advance directive” family of documents in the United 
States in that it can be put in place well before the need 
for end-of-life decision-making.25 The PPC consists 
of a form on which people answer three open-ended 
questions about 1) what has been happening to them 
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regarding their health, 2) their “preferences and priori-
ties” for future care, and 3) where they would like to be 
cared for in the future. There is also space for recording 
any changes in preferences and priorities as well as for 
contact information on people involved in the patient’s 
care. The document containing this information is to be 
taken by the patient to the various places in which he or 
she may receive care; in that way, medical staff can fol-
low the patient’s wishes should his or her capacity be lost 
toward the end of life. 
The Gold Standards Framework. The Gold Standards 
Framework (GSF), developed as a grassroots initiative 
by Yorkshire general practitioner Dr. Keri Thomas, is 
designed to assist primary care teams in providing the 
best possible care for people nearing the end of their lives. 
The Framework’s goals are to provide high-quality care 
that is consistent with patients’ preferences, anticipates 
and plans for their needs, and is more home-based than 
hospital-based.26 
Application of the GSF begins with identify-
ing people who may be in their last year or so of life, as 
opposed to hospitalized patients who are already close 
to death. Identification may begin with the so-called 
surprise question that doctors could ask themselves, 
“Would it surprise you if this patient died in the next 
year?”27 The Royal College of General Practitioners has 
developed a set of clinical indicators to help clinicians 
recognize differences in the trajectory of dying with dif-
ferent conditions (e.g., cancer, heart failure, HIV/AIDS, 
or dementia).28 The second step is to assess the patient’s 
current and future clinical and personal needs, taking 
into account his or her preferences and those of the fam-
ily. The third step is to develop and carry out a plan to 
meet those needs and preferences. This involves the “7 
Cs”: communication, coordination, control of symptoms, 
continuity of care, continued learning, caregiver support, 
and care of the dying. 
Originally developed for cancer patients, the 
GSF can now be used in a variety of settings for any 
patient with a life-limiting condition. The National Gold 
Standards Framework Center has prepared guidance for 
physicians and nurses in primary care, care (nursing) 
homes, and hospitals in carrying out the GSF.29 At the 
time the End of Life Care Strategy was prepared, esti-
mates were that about 50 percent of the GP practices in 
England reported using the GSF, though not all of them 
were fully implementing it, and there was great regional 
variation.30
The Delivering Choice Programme. The Delivering 
Choice Programme was begun in 2004 by Marie Curie 
Exhibit 2. Models and Programs Used in Developing the End of Life Care Strategy
Model/Program Implemented by Focus Aim
Preferred Priorities for Care Patients Document	patient	
preferences	for	end-of-life	
care
Facilitate	care	that	meets	
patient’s	preferences
Gold Standards Framework Primary	care	teams Guide	care	in	patients’	last	
year	of	life
Enable	patients	to	receive	
high-quality	end-of-life	care	
as	much	as	possible	at	
home
Delivering Choice Programme Discharge	and	
home	care	nurses
Facilitate	end-of-life	care	
at	home	for	hospitalized	
patients
Enable	patients	near	end	of	
life	to	be	cared	for	at	home	
if	they	wish
Liverpool Care Pathway for  
the Dying Patient
Multiprofessional	
teams	in	hospitals
Meet	psychological,	
spiritual,	and	physical	
needs	of	patients	in	their	
last	days	and	hours	of	life
Provide	dying	patients	with	
comfort,	pain	management,	
and	relief	from	distressing	
symptoms	
Source: Adapted by author from materials at the following sources: http://www.endoflifecareforadults.nhs.uk/tools/core-tools/preferredprioritiesforcare; 
http://www.goldstandardsframework.nhs.uk; http://www.mariecurie.org.uk/en-gb/healthcare-professionals/innovation/Delivering-Choice-Programme/; http://www.liv.ac.uk/mcpcil/
liverpool-care-pathway/.
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Cancer Care, one of Britain’s largest health charitable 
organizations, which operates nine hospices and provides 
free nursing care to terminally ill people who wish to be 
cared for and to die at home, supported by their families. 
The program, aimed at overcoming locally identified 
barriers to the effective provision of end-of-life care, has 
several key elements. They include “discharge commu-
nity link nurses” who facilitate discharge from hospitals 
by coordinating home care services, the provision of 
information and advice to patients, the conveyance of 
patients’ needs to home health care teams, and “rapid 
response teams” that make emergency as well as planned 
visits to patients in their homes during off hours. 
An evaluation of the Delivering Choice 
Programme in Lincolnshire by the Kings Fund in 2007 
found a substantial increase (from 19% to 42%) in 
deaths at home among patients who had used the pro-
gram’s services and no change among patients who had 
not.31 No differences were found in hospital usage or in 
costs over the last eight weeks of life. A separate evalua-
tion in Lincolnshire, based on assessments of patients and 
their families, found that rapid response teams (RRTs) 
were effective in providing care and support, particularly 
for cancer patients in crisis at night.32 The Programme 
enabled some families to keep patients at home until 
they died, and the availability of services by phone pro-
vided reassurance that help could be summoned when 
needed. One-third of the cancer patients who died in the 
two locales studied had used the service, and 73 percent 
of cancer patients who died at home had received RRT 
support. 
The Liverpool Care Pathway for the Dying Patient. 
The Liverpool Care Pathway for the Dying Patient 
(LCP), which was developed in the 1990s by the Royal 
Liverpool University Hospital and the Marie Curie 
Hospice Liverpool,33 focuses primarily on the last days 
and hours of life of hospitalized patients. It provides care-
givers with guidance on meeting the physical, psycho-
logical, and spiritual needs of dying patients, including 
comfort measures, anticipatory symptom control, and 
the discontinuance of interventions that are not confer-
ring benefit. The LCP is brought into use for particular 
patients when a trained multiprofessional team agrees 
that the patient is dying and that all possible ways to 
reverse the current situation have been considered and 
found to be either ineffective or infeasible.34 The patient’s 
need for comfort, pain management, and relief of dis-
tressing symptoms are to be addressed and reassessed at 
least every four hours. Rescue treatment can be resumed 
if changes in the patient’s condition warrant it. 
The LCP lays out detailed steps regarding what 
information should be obtained and documented about 
the patient’s wishes. The pathway also contains guid-
ance about informing the patient and relatives when the 
focus of care has changed and about communicating after 
death with the patient’s family and general practitioner. 
At the time the End of Life Care Strategy was published 
in 2008, the LCP had been implemented in at least three 
hospital wards in more than 80 percent of hospital trusts, 
but it had been introduced to all appropriate wards 
by only 17 percent of trusts.35 The Strategy sought to 
increase the use of the LCP.
IMPLEMENTATION OF THE END-OF-LIFE 
CARE STRATEGY
The Strategy laid out actions to make change happen.36 
One set of actions was focused on increasing public 
awareness that patient care at the end of life could be 
guided in ways that responded to patients’ preferences. A 
second set was aimed at improving the capacity of pur-
chaser organizations within the National Health Service 
(primary care trusts at that time) to carry out the respon-
sibilities implied by the end-of-life pathway. A third set 
of actions involved providing guidance to, and creating 
expectations and responsibilities for, the organizations 
and professionals that provide care to patients at the end 
of life. And a fourth was the development of a set of mea-
sures by which progress could be assessed.
Publishing a strategy is one matter; changing 
the services provided by the NHS and its 1.3 million 
employees to England’s 50 million people (of whom 
about half a million die in a given year) is quite another. 
The number of people responsible for implementing the 
Strategy was remarkably small—fewer than half a dozen 
people each in the Department of Health and the NHS. 
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care, they were essential steps in applying the Gold 
Standards Framework. 
Markers of progress. The implementation of the 
Strategy, like its development, emphasized the impor-
tance of evidence. Soon after the Strategy’s publication in 
2008 the Department of Health drafted a set of “quality 
markers” for end-of-life care and then invited comment; 
in 2009 the agency published a revised set of quality 
markers based on the resulting feedback.40 These markers 
were structure and process measures, as well as measures 
of compliance for use in audits and evaluations. There 
were separate measures for commissioners (purchasers) 
and for the various kinds of providers—e.g., primary care 
providers, hospitals, hospices, and ambulance services. 
For commissioners, there were markers for activities in 
increasing public awareness, strategic planning, oversight 
of providers’ activities and service capacities, coordination 
across organizational boundaries, workforce planning, 
and monitoring. For providers, quality markers focused 
heavily on capacity, with appropriate variations for the 
type of provider. (See Exhibit 3 for the top 10 quality 
markers for providers.)
Progress reports. The Department of Health issued 
progress reports one year and two years after publication 
of the Strategy. Progress was reported largely in terms 
of steps taken by strategic health authorities (SHAs) 
and primary care trusts (PCTs). Progress reporting was 
rather cumbersome, because both types of entities were 
given much autonomy in adopting the End of Life Care 
Strategy. For example, improving end-of-life care was one 
of 50 priorities from which PCTs had to choose eight, 
and SHAs could develop their own emphases—one 
might focus on changing public attitudes, another on 
the use of electronic health records to coordinate care, 
and another on implementing the Delivering Choice 
Programme (to help develop local services that enable 
palliative care patients to be cared for in the place of their 
choice). The hope was that the SHAs would learn from 
each other’s experiences with different components of the 
overall Strategy.
The End of Life Care Strategy was incorporated 
into the operating framework of the NHS, and it was 
made a priority in the overall quality-improvement effort 
known as the Next Stage Review. This effort worked 
through the structure of the 10 regional strategic health 
authorities, which oversee the 152 primary care trusts in 
England that purchase the services of general practitio-
ners, hospitals, and other providers within the NHS. (In 
the wake of the elections of 2010, the regional authorities 
and primary care trusts are to be phased out in 2013 and 
replaced by physician-based purchasing arrangements.37) 
Specific implementation activities, often in the 
form of pilot projects, have varied across these entities, 
and lessons are being shared. For example, guidance 
(including information about “good practices”) was 
published so as to assist in the purchasing of end-of-life 
services and in providing such care. Implementation 
made use of incentives as well, and also it included the 
collection of data indicative of progress. The Department 
of Health also had some new money (£286 million 
[US$460 million]over the first two years) with which to 
encourage implementation of the Strategy’s directives. 
Some of this funding was used for workforce develop-
ment, but most of it went to the primary care trusts for 
their use in purchasing services. 
One of the most direct implementation tools, 
initiated before the Strategy was published (though 
while it was in development), involved the Quality and 
Outcomes Framework (QOF) that was part of the NHS’s 
standard contract with general practitioners. Provisions 
related to palliative care were included among the QOF 
measures on which GPs received incentive payments 
for their performance.38 To encourage providers to pay 
attention to the needs of patients who might be entering 
an end-of-life situation, the NHS gave GPs three QOF 
points for creating a list of their patients thought to need 
palliative care or to be in their last year or so of life; and 
the NHS awarded three additional points for reviewing 
those patients at multidisciplinary team meetings. Data 
reported for the one-year period ending March 2010 
showed that 94 percent of the 8,305 practices reporting 
met the former target and 84 percent the latter.39 Though 
these physician actions did not themselves change patient 
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In the first year, some 69 PCTs (close to half ) 
designated improving end-of-life care as one of their 
eight priorities. The tools they possessed for achieving 
this goal were some funding for enhancing the training 
of health care providers, a reporting system for the per-
centage of deaths that occur at home, and the offering of 
incentives to general practitioners to recognize and pay 
attention to their patients who are nearing the end of life 
(the first step in the care pathway). The only outcome 
measure in this set was percentage of all deaths that occur 
at home. In recognition that additional outcome mea-
sures are needed, pilot testing has been taking place for a 
national survey (entitled VOICES) that solicits the views 
of bereaved relatives about the end-of-life care of their 
loved one.41 
The second annual report attested to continued 
progress on several fronts.42 One was the launching in 
early 2010 of an Internet-based education program for 
health and social care professionals regarding end-of-life 
care. Another was the availability of capital funding for 
several new hospice facilities. Pilots were initiated both 
for the local registries of people facing end of life as well 
as for the VOICES survey of the bereaved. Two widely 
recognized experts in end-of-life care—Dr. Teresa Tate, 
the medical advisor for Marie Curie Cancer Care, and 
Professor John Ellershaw, who had led development of 
the Liverpool Care Pathway—were appointed deputy 
national clinical directors for end-of-life care. The report, 
and the implementation effort itself, continued to focus 
on identifying and publicizing examples of good prac-
tices, with the aim of encouraging their wider adoption.
There were also some early lessons. One was that 
the Vital Sign measure for end-of-life care—the number 
of people dying at home—was flawed; for many people, 
a nursing or care home had become their residence and 
was therefore an appropriate place for death for people 
not wanting to die in a hospital. The report thus stressed 
the need to recognize care homes in implementing the 
strategy.
Two other related problems were recognized as 
well. First, primary care trusts had been very uneven in 
their efforts to implement the strategy, leading to the 
concern that a post code (zip code in American terms) 
lottery would determine what care people received at the 
end of life. Second, the funds that had been allocated to 
PCTs for end-of-life care had not been “ring-fenced,” and 
a third of them were unable to report on what they had 
done with that money. (The PCTs that had made best 
Exhibit 3. Top 10 Quality Markers for Providers
1.	 Have	an	action	plan	for	delivery	of	high-quality	end-of-life	care	that	encompasses	all	patients’	diagnoses	and	
is	reviewed	for	impact	and	progress.
2.	 Institute	effective	mechanisms	to	identify	those	who	are	approaching	the	end	of	life.
3.	 Ensure	that	people	approaching	the	end	of	life	are	offered	a	care	plan.
4.	 Ensure	that	individuals’	preferences	and	choices,	when	they	wish	to	express	them,	are	documented	and	
communicated	to	appropriate	professionals.
5.	 Ensure	that	the	needs	of	caregivers	are	appropriately	assessed	and	recorded.
6.	 Have	mechanisms	in	place	to	ensure	that	care	for	individuals	is	coordinated	across	organizational		
boundaries	24/7.	
7.	 Have	essential	services	available	and	accessible	24/7	to	all	those	approaching	the	end	of	life	who		
need	them.
8.	 Be	aware	of	end-of-life	training	opportunities	and	enable	workers	to	access	appropriate	programs	relevant	to	
their	needs.
9.	 Adopt	a	standardized	approach	(the	Liverpool	Care	Pathway	or	equivalent)	to	care	for	people	in	the	last	days	
of	life.
10.	Monitor	the	quality	and	results	of	end-of-life	care	and	submit	relevant	information	for	local	and	national	audits.	
Source: Department of Health, End of Life Care Strategy: Promoting High Quality Care for All Adults at the End of Life (London: Department of Health, 2008).
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use of the funding were the same ones that had histori-
cally done well at end-of-life care.) But these problems 
resulted from limitations in the administrative struc-
ture for implementing a national strategy, not from the 
Strategy itself. 
STRENGTHS OF THE STRATEGY
Although the NHS is still early in the 10-year hori-
zon envisioned for implementing the End of Life Care 
Strategy, there is reason for optimism. This brief has 
already identified a number of strengths in the English 
approach to improving end-of-life care, including com-
prehensiveness; heightened public awareness; success-
ful models of care to build on; enhanced training of 
health professionals; an emphasis on evidence; and the 
use of incentives, education, and oversight as levers of 
implementation.  
A striking characteristic of the Strategy itself is 
its level of acceptance by the leadership of the relevant 
medical societies (British Medical Association, Royal 
College of Nursing, Royal College of Physicians, and 
Royal College of General Practitioners) and caregiving 
organizations (Macmillan Cancer Support and Marie 
Curie Cancer Care). Reasons for this acceptance may 
include the following: the participatory process by which 
the Strategy was developed, involving work over two 
years by a distinguished advisory board and six work-
ing groups plus consultations with 300 stakeholders, 
was widely admired; the clinical directors of all of the 
strategic health authorities were involved in the process; 
the development and implementation of the Strategy 
was led by an eminent palliative-medicine specialist, Sir 
Mike Richards, national clinical director for end-of-life 
care; the Strategy was built upon, and harmonious with, 
previous policy initiatives; and it fit into a much broader 
effort, undertaken in the 2000s, to improve care in the 
National Health Service—for example, a policy thread 
that the Strategy shared with several components of this 
overall effort was to expand patient choice.  
CHALLENGES FACING THE STRATEGY
Several end-of-life challenges remain. First, successful 
implementation ultimately depends on the willingness 
of individual physicians to build the relationships and 
undertake the conversations that reveal patients’ wishes—
and to respond accordingly. Effecting behavioral change 
among physicians is always difficult, and the literature 
on the problem of diffusion of innovation in health care 
organizations is huge.43
A second challenge arises from the fact that the 
triggering act for initiating end-of-life care—recogniz-
ing when particular patients are entering the end-of-life 
situation—can be difficult to do and is potentially con-
troversial.44 The Gold Standards Framework is envisioned 
for implementation a year or more in advance of patients’ 
deaths. Regarding patients who die in hospitals, many 
do so unexpectedly and thus might not be subject to the 
Liverpool Care Pathway. On the other hand, the pos-
sibility that hospitalized patients could be incorrectly 
identified as dying raises the danger of misapplying the 
Pathway. A controversy developed in fall 2009 when six 
experts wrote a letter to the Daily Telegraph claiming that 
some patients were incorrectly being put on the Pathway. 
The problem, it appears, was less in the Pathway and its 
elements than in the need for better training of clinical 
personnel in making the difficult judgment that a patient 
is actually in the process of dying. 
A third challenge, which can arise in any policy 
implemented by government, is the possibility that the 
party that champions it may be voted out of office. This 
in fact happened in England in 2010 with the replace-
ment of the Labor government. In several interviews that 
the author conducted shortly before that election, no 
one believed the Strategy was vulnerable to a change in 
government because the need for improving end-of-life 
care was widely recognized and the Strategy had gener-
ated almost no organized opposition. Also, because the 
Strategy was clinically led and “owned,” it was more 
about professional standards than political ones. But only 
a few months after the election the coalition government 
proposed to eliminate one mechanism by which the 
Strategy was being implemented—the strategic health 
authorities—and to replace the primary care trusts with 
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a purchasing mechanism controlled by general practi-
tioners. More reassuring has been the public statement 
by Paul Burstow, the current Minister of State, that the 
Strategy is to be taken further and faster.45 End-of-life 
care is also addressed in several documents of the new 
government, including the Coalition Agreement (relat-
ing to a per-patient funding system for palliative care). 
A review of how this system might be implemented is 
under way.
A final challenge pertains to marking progress. 
Mechanisms are in place to measure various structural 
and procedural aspects of the quality of end-of-life care, 
but measuring the outcomes of the Strategy itself is more 
difficult. The only available outcome measure is the per-
centage of deaths that occur at home or in the care homes 
that are the final residences of many people. The planned 
VOICES surveys to collect information on the experi-
ences of bereaved relatives should provide additional use-
ful markers of progress, as may the ongoing analyses of 
complaints within the NHS. 
COMPARISON WITH THE UNITED STATES
End-of-life care in the United States has already been 
hugely influenced by ideas associated with hospice and 
palliative care in the U.K. Thus, for example, the patient-
choice issues that animate the English End of Life Care 
Strategy, including legal developments pertaining to 
patients’ advance directives regarding end-of-life treat-
ment, are now familiar to U.S. stakeholders. Americans, 
however, often go their own way, as with their organized 
payment system for hospice care, which is more advanced 
than its English counterpart; such services are built into 
the Medicare program rather than largely supported by 
charity, as in the U.K. And the share of deaths occur-
ring in hospitals is smaller in the United States than in 
England—45 percent (37 percent if only inpatient deaths 
are counted) compared with 58 percent in England.46 
Despite such differences, it is striking, when 
comparing end-of-life care in the two countries—which 
have such different health care systems—that the chal-
lenges in end-of-life care are so similar. There is a general 
reluctance in both countries to discuss preferences for 
end-of-life care, and there are shortages of professionals 
with the requisite training. Both countries struggle with 
what we described earlier as “boundary” challenges: going 
beyond cancer care to meet the needs of all patients with 
advanced, progressive, and incurable illnesses; extend-
ing end-of-life care beyond the province of hospice and 
palliative-care specialists; initiating services oriented 
toward the end of life but before the patient’s final days; 
and gaining acceptance of the idea that palliative-care ser-
vices can be appropriate no matter the stage of a patient’s 
disease.47
Meanwhile, important elements of the British 
approach that do not depend on the existence of a 
National Health Service may be applicable to the United 
States. The Gold Standards Framework and the Liverpool 
Care Pathway both provide guidance that could be useful 
for American physicians and other health professionals, 
and research on the Delivering Choice Programme shows 
that the introduction of services such as discharge com-
munity link services and rapid response teams can mark-
edly enhance the feasibility of caring for U.S. patients at 
home during their final days, if that is their preference. 
The idea of using survey research (e.g., the VOICES 
project) to obtain survivors’ assessments of the quality of 
end-of-life care of their loved one is another idea worth 
emulating, as was suggested in the Institute of Medicine 
report Describing Death in America.48 The last federally 
funded mortality follow-back survey in the United States 
was done in 1993.
Other aspects of the English approach that may 
be useful in improving end-of-life care in the United 
States include: the strategies for encouraging and helping 
physicians to recognize when patients are entering one of 
the trajectories that may end in death and to implement 
approaches to care that are based on that recognition; the 
use of “death at home” as a metric for measuring prog-
ress; the focus on improving the skills of clinical and care-
giving personnel through the use of Web-based training; 
and the development of a national improvement pathway 
such as the Gold Standards Framework. However, the 
English approach that the government should try to 
increase awareness of the need for end-of-life care plan-
ning contrasts strongly with the situation in the United 
States, where the idea of compensating physicians for 
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having end-of-life care conversations with their patients 
prompted fears, however unfounded, of the creation of 
“death panels” that would determine who deserved to 
live.
When asked about important lessons for the 
United States, most of our English interviewees cited 
the End of Life Care Strategy itself—the fact that a set 
of ideas about patient choice and palliative care could be 
built into the very structure of the health care system. My 
own choice for the most important lesson pertains to the 
value of approaching end-of-life services as a quality-of-
care issue for which measures are needed. Work on the 
development of such measures is taking place in both 
countries.49
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